Menu Back to Latin-America-Regulatory-Conference


Join global regulators, industry, and academia to engage in a series of strategic discussions on current regulatory landscape, globalization, and harmonization initiatives in Latin America.

DIA brings you a symposium with interactive dynamics, where you will be engaged in discussions with key stakeholders influencing the advancement and implementation of regulatory convergence initiatives in Latin America.

Join us to discuss multi-regional cooperation, global harmonization, and best practices related to Latin America’s regulatory landscape. Sessions will highlight regulatory approaches and good practices to ensure reliance in Latin American and strategic initiatives to improve collaboration and cooperation.

Who should attend?

Professionals involved in:

  • Drug Regulation
  • Clinical Research and Development
  • Medical and Scientific Affairs
  • Quality Assurance
  • Research and Development
  • Strategic Sourcing/Planning
  • Regulatory Affairs

Learning objectives

At the completion of this conference, the participant should be able to:
  • Identify the current regulatory landscape across Latin America including updates on harmonization and convergence efforts, and individual regional priorities from various National Regulatory Authorities
  • Discuss how emerging regulatory trends and new technologies impact the development and lifecycle of medical products
  • Establish various approaches and best practices to promote regulatory reliance in Latin America

Program Committee

  • Maria  Guazzaroni Jacobs, PhD
    Maria Guazzaroni Jacobs, PhD Director, Quality and Regulatory Policy (QRP), Global Supply
    Pfizer Inc, United States
  • Cammilla  Horta Gomes, MA, MPharm
    Cammilla Horta Gomes, MA, MPharm LATAM Regulatory Policy Lead
    Roche, Brazil
  • Livia  Lopes
    Livia Lopes LatAm Regulatory Affairs Policy Manager
    Novartis, United States
  • Michele Aline de Mello, RPh
    Michele Aline de Mello, RPh Regulatory Affairs Manager LATAM, Global Q&R Strategy and Compliance
    Roche Diagnostica do Brasil Ltda, Brazil
  • Maria Cristina  Mota Pina, MBA
    Maria Cristina Mota Pina, MBA Director, Regulatory Policy and Intelligence -Japan, Emerging Markets, Australia
    AbbVie, Inc., United States
  • Juliana  Perlow
    Juliana Perlow Director, Regulatory Affairs-CMC, GRACS CMC – Latin America
    MSD, Brazil
  • Ana Patricia  Pineda, MSc
    Ana Patricia Pineda, MSc International Regulatory Analyst, OIP, OGROP, OC
    US FDA, Mexico
  • Renata De Lima Soares
    Renata De Lima Soares Regulation and Health Surveillance Specialist
    Anvisa, Brazil
  • Sonia  Viejobueno, LLM
    Sonia Viejobueno, LLM Latin America Lead, Global Regulatory Policy and Intelligence
    The Janssen Pharmaceutical Companies of Johnson & Johnson, Argentina
Load More

Contact us

Registration Questions?

Send Email

Exclusive Podcast

Promoting Patient-Centric Business: MedComm in Latin America

Additional Information

Latin America Regulatory Resource Kit

On Demand Content Preview Webinar

Regulating Medicines in a Globalized World
Register Today!

Digital Learning Catalog

DIA Learning: eLearning Soultions